《原发性肝癌诊疗指南(2024年版)》解读

Interpretation of guidelines for the diagnosis and treatment of primary liver cancer(2024 edition)

2017年6月国家卫生和计划生育委员会发布了《原发性肝癌诊疗规范(2017年版)》,该规范在肝癌的诊断、分期及治疗方面提出推荐性意见具有重要意义,此后国内外在原发性肝癌研究方面不断出现符合循证医学原则的高级别证据。为此,国家卫生健康委员会修订更新颁布了《原发性肝癌诊疗指南(2024年版)》,本文对新版指南的更新要点进行解读,以期更好地指导临床。

In June 2017,National Health Commission of the People’s Republic of China released Guidelines for the diagnosis and treatment of primary liver cancer(2017 edition),which provided important recommendations for the diagnosis,staging,and treatment of liver cancer.Since then,high-level evidence in line with the principles of evidence-based medicine has been continuously obtained from the research on primary liver cancer in China and globally.Therefore,National Health Commission released Guidelines for the diagnosis and treatment of primary liver cancer(2024 edition).This article gives an interpretation of the updated key points in the guidelines,in order to better guide clinical practice.